← SearchTHERAPEUTIC TARGETING OF FLCN-DEFICIENT RENAL CANCERS...NEW GRANT, SIGNED 9/17/2019, EFFECTIVE 9/30/2019, DISTRIBUTED 9/18/2019, FAADC 9/18/2019$670,640FY2019Defense Health AgencyDODThe General Hospital CorporationInvestigatorsView source on USAspending →